Dimensional Fund Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-454,213
Closed -$13.5M 3455
2023
Q4
$13.5M Sell
454,213
-726,531
-62% -$14.5M ﹤0.01% 2185
2023
Q3
$18.7M Sell
1,180,744
-8,475
-0.7% -$141K 0.01% 1957
2023
Q2
$22.4M Sell
1,189,219
-2,578
-0.2% -$30.4K 0.01% 1874
2023
Q1
$4.58M Sell
1,191,797
-1,212,259
-50% -$5.17M ﹤0.01% 2508
2022
Q4
$11.9K Sell
2,404,056
-136,795
-5% -$742K ﹤0.01% 2118
2022
Q3
$12.1M Buy
2,540,851
+929,775
+58% +$4.9M ﹤0.01% 2083
2022
Q2
$7.25M Buy
+1,611,076
New +$7M ﹤0.01% 2332
2022
Q1
Sell
-20,517
Closed -$152K 3576
2021
Q4
$152K Sell
20,517
-102,709
-83% -$638K ﹤0.01% 3384
2021
Q3
$699K Sell
123,226
-406,595
-77% -$2.35M ﹤0.01% 3120
2021
Q2
$3.49M Buy
+529,821
New +$3.7M ﹤0.01% 2711
2015
Q1
Sell
-1,100
Closed -$7K 3405
2014
Q4
$7K Hold
1,100
﹤0.01% 3467
2014
Q3
$12K Hold
1,100
﹤0.01% 3472
2014
Q2
$13K Hold
1,100
﹤0.01% 3521
2014
Q1
$16K Sell
1,100
-150
-12% -$2.37K ﹤0.01% 3517
2013
Q4
$18K Hold
1,250
﹤0.01% 3474
2013
Q3
$21K Sell
1,250
-300
-19% -$5.27K ﹤0.01% 3498
2013
Q2
$26K Buy
+1,550
New +$25.1K ﹤0.01% 3480

Other funds holding IMGN

Dimensional Fund Advisors's IMGN Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 454,213 shares — an estimated $13.5M sold.

Dimensional Fund Advisors first reported a position in IMGN in Q2 2013 and held it in 17 quarters. The position peaked at $22.4M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 454,213 Immunogen Inc shares in Q1 2024, an estimated $13.5M.
  • Dimensional Fund Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 17 quarters.
  • Dimensional Fund Advisors's Immunogen Inc position peaked at $22.4M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.